查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球血管內導管市場
市場調查報告書
商品編碼
1255882

2023-2030 年全球血管內導管市場

Global Intravascular Catheters Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球血管內導管市場預計將經歷有利可圖的增長。

血管內導管是一種細而柔韌的管子，通過皮膚上的小切口插入腎臟的腎盂。 導管用縫合線或膠帶固定，並連接到收集尿液的引流袋。 血管內導管可用於短期或長期腎引流，具體取決於患者的情況。

市場動態

全球老年人口不斷增長

在世界範圍內，人們的壽命越來越長。 現在預計大多數人都可以活到 60 歲以後。 在世界範圍內，老年人口的數量和比例都在增加。 根據世界衛生組織的數據，到 2030 年，地球上六分之一的人將超過 60 歲。 屆時，60 歲以上的人口將從 2020 年的 10 億增加到 14 億。 到 2050 年，地球上 60 歲以上的人口數量將翻一番。 （21 億人）。 從 2020 年到 2050 年，80 歲及以上的人口數量預計將增加兩倍，達到 4.26 億。 隨著老年人口的不斷增長，靜脈導管的使用在老年人護理中變得越來越重要。 靜脈導管通常用於老年患者，以進入血液以給藥藥物、液體和營養物質。

靜脈導管的替代品

靜脈導管是現代醫學中的重要工具，但有多種替代品可用於類似目的。 這些替代方案包括口服藥物、肌肉注射和皮下注射。 這可能會限制對靜脈導管的需求，尤其是當這些替代品有效時。 靜脈導管的成本可能是一個限制因素，尤其是在資源匱乏的環境中。 靜脈導管相對昂貴，如果發生並發症或感染，成本會增加。

COVID-19 影響分析

COVID-19 大流行對血管內導管市場產生了相當大的影響。 一方面，由於疫情期間對醫療器械和耗材的需求增加，部分地區對血管內導管的需求激增。 隨著大流行的蔓延，對重症監護服務的需求猛增，例如為需要重症監護的患者使用血管內導管。 因此，對導管的需求增加了，尤其是在一些受疫情影響嚴重的地區。 為了遏制 COVID-19 的傳播，許多醫療保健提供者正在推遲非必要的醫療程序，包括為選擇性程序放置血管內導管。

內容

第一章調查方法及範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按產品分類的片段
  • 使用特定片段
  • 最終用戶的片段
  • 區域摘要

第四章市場動態

  • 影響因素
    • 司機
      • 腎衰竭患者人數上升
      • 增加慢性病的患病率
    • 約束因素
      • 血管內留置導管的發病率和死亡率風險
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格波動
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章副產品

  • 短 PIVC
  • 集成/封閉式 PIVC

第 8 章應用

  • 腫瘤學
  • 胃腸病學
  • 腎臟疾病
  • 感染
  • 其他

第 9 章最終用戶

  • 醫院
  • 門診手術診所
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場分析/份額分析
  • 併購分析

第12章公司簡介

  • 歐姆龍公司
    • 公司簡介
    • 產品組合和說明
    • 財務摘要
    • 主要發展
  • Koninklijke Philips N.V
  • Cook Medical
  • Allied Healthcare Products, Inc
  • Becton, Dickinson, and Company
  • Agilent Technologies
  • Medline Industries, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • GF Health Products, Inc

第13章附錄

  • 關於我們和我們的服務
  • 聯繫我們
簡介目錄
Product Code: MD1473

Market Overview

The global intravascular catheters market reached US$ XX million in 2022 and is projected to witness lucrative growth by reaching up to US$ XX million by 2030. The market is growing at a CAGR of xx% during the forecast period (2023-2030).

The Intravascular catheter is a thin, flexible tube inserted through a small incision in the skin into the renal pelvis of the kidney. The catheter is secured with a stitch or adhesive tape and connected to a drainage bag, which collects the urine. Intravascular catheters may be used for short-term or long-term kidney drainage, depending on the patient's medical condition.

Market Dynamics

The growing older population worldwide

Globally, people are living longer. Today, the majority of people may anticipate living into their 60s and beyond. The number of older people and their share of the population is increasing in every nation worldwide. Based on WHO data one in six individuals on the planet will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of persons in the globe who are 60 years or older will double by 2050. (2.1 billion). Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. As the geriatric population continues to grow, the use of IV catheters is becoming increasingly important in the care of older adults. IV catheters are commonly used in geriatric patients to provide access to the bloodstream for the delivery of medications, fluids, and nutrition.

Alternative available for intravenous catheters

Intravenous catheters are an important tool in modern medicine, there are several alternatives available that can be used for similar purposes. These alternatives include oral medications, intramuscular injections, and subcutaneous injections. This can limit the demand for IV catheters, particularly in cases where these alternatives are effective. The cost of IV catheters can be a limiting factor for their use, particularly in resource-limited settings. IV catheters can be relatively expensive, and the cost can increase if complications or infections arise.

COVID-19 Impact Analysis

The COVID-19 pandemic had a considerable impact on the intravascular catheter market. On the one hand, the increased demand for medical devices and supplies during the pandemic has led to a surge in demand for intravascular catheters in certain regions. As the pandemic has spread, there has been a surge in demand for critical care services, including the use of intravascular catheters for patients who require intensive care. This has led to increased demand for catheters in certain regions, particularly those that have been hit hardest by the pandemic. To reduce the spread of COVID-19, many healthcare providers have postponed non-essential medical procedures, including the placement of intravascular catheters for elective procedures.

Segment Analysis

The global intravascular catheter market is segmented based on product, application, and region.

Owing to their versatility, the oncology product

Intravascular catheters are commonly used in oncology for the administration of chemotherapy, as well as for the collection of blood samples for monitoring treatment efficacy and disease progression. Peripherally Inserted Central Catheters (PICCs) are another type of intravascular catheter that is commonly used in oncology. These catheters are typically inserted through a peripheral vein in the arm and are threaded through to the superior vena cava. PICCs provide a less invasive alternative to CVCs and can be used for the administration of chemotherapy drugs, as well as for the collection of blood samples.

Geographical Analysis

The growing demand for healthcare services and the increasing geriatric population

Asia Pacific region has emerged as the dominant market for intravascular catheters in recent years. This can be attributed to several factors, including the growing demand for healthcare services, the increasing prevalence of chronic diseases, and the expanding geriatric population. As healthcare systems in the Asia Pacific region continue to expand and modernize, there has been a growing demand for medical devices and supplies, including intravascular catheters. The Asia Pacific region has witnessed a rapid rise in the prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer. This has led to an increased demand for intravascular catheters for the administration of medication and other treatments.

Competitive Landscape

The major global players in the market include: Omron Corporation, Koninklijke Philips N.V, Cook Medical, Allied Healthcare Products, Inc, Becton, Dickinson and Company, Agilent Technologies, Medline Industries, Inc., Boston Scientific Corporation, Johnson & Johnson, GF Health Products, Inc.

Why Purchase the Report?

  • To visualize the global Intravascular Catheters market segmentation based on product, application, end user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous Intravascular Catheters market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global intravascular catheters market report would provide approximately 61 tables, 58 figures, and 195+ pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number Of Kidney Failures
      • 4.1.1.2. Increasing Prevalence Of Chronic Diseases
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. The risk of Morbidity and Mortality Presented by Intravascular Catheters
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Short PIVC*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Integrated/Closed PIVC

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Oncology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Gastroenterology
  • 8.4. Renal Disease
  • 8.5. Infectious Diseases
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgery Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Omron Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Koninklijke Philips N.V
  • 12.3. Cook Medical
  • 12.4. Allied Healthcare Products, Inc
  • 12.5. Becton, Dickinson, and Company
  • 12.6. Agilent Technologies
  • 12.7. Medline Industries, Inc.
  • 12.8. Boston Scientific Corporation
  • 12.9. Johnson & Johnson
  • 12.10. GF Health Products, Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us